Identification and Validation of an Anthracycline/Cyclophosphamide–Based Chemotherapy Response Assay in Breast CancerJude M. Mulligan, Richard D. Kennedy, Paul B. Mullan et al.|JNCI Journal of the National Cancer Institute|2014Cited by 127
Immunohistochemistry in the era of personalised medicineClare McCourt, Manuel Salto‐Tellez, David Boyle et al.|Journal of Clinical Pathology|2012Cited by 45
Analysis of wntless (WLS) expression in gastric, ovarian, and breast cancers reveals a strong association with HER2 overexpressionJonathan Stewart, Manuel Salto‐Tellez, Jacqueline A. James et al.|Modern Pathology|2014Cited by 30
Molecular classification of non-invasive breast lesions for personalised therapy and chemopreventionNiamh E. Buckley, Manuel Salto‐Tellez, David Boyle et al.|Oncotarget|2015Cited by 10
A strong correlation between expression of Wntless and of human epidermal growth factor receptor 2 in gastric, ovarian, and breast cancers suggests a novel-signalling pathway involving NFκB and STAT3Jonathan Stewart, Manuel Salto‐Tellez, Jacqueline A. James et al.|The Lancet|2013Cited by 1